IxCell Biotechnology Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
78
- Latest Deal Type
-
Series B1
- Financing Rounds
-
7
IxCell Biotechnology General Information
Description
Manufacturer of advanced bioseparation media and chromatography products aims to support high-purity biopharmaceutical production and diagnostic applications. The company's offerings feature protein A resins, ion-exchange and size-exclusion chromatography materials, and customizable purification systems for bioprocess workflows, helping biotech firms, pharmaceutical manufacturers, and diagnostic labs achieve consistent purity, yield, and scalability, enabling efficient and reliable separation infrastructure across life-science industries.
Contact Information
Website
www.ixcellbio.comCorporate Office
- Building 6
- Number 151 Libing Road, Pudong New Area
- Shanghai, 201203
- China
Corporate Office
- Building 6
- Number 151 Libing Road, Pudong New Area
- Shanghai, 201203
- China
IxCell Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
IxCell Biotechnology Signals
IxCell Biotechnology Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
IxCell Biotechnology FAQs
-
When was IxCell Biotechnology founded?
IxCell Biotechnology was founded in 2013.
-
Where is IxCell Biotechnology headquartered?
IxCell Biotechnology is headquartered in Shanghai, China.
-
What is the size of IxCell Biotechnology?
IxCell Biotechnology has 78 total employees.
-
What industry is IxCell Biotechnology in?
IxCell Biotechnology’s primary industry is Biotechnology.
-
Is IxCell Biotechnology a private or public company?
IxCell Biotechnology is a Private company.
-
What is IxCell Biotechnology’s current revenue?
The current revenue for IxCell Biotechnology is .
-
Who are IxCell Biotechnology’s investors?
Shandong Sito Bio-technology, Gansu State Investment Fund, Hangzhou Shenghui Jingchen Investment Management, Capitallink, and China-Singapore Suzhou Industrial Park Development Group are 5 of 16 investors who have invested in IxCell Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process